TrialBritish journal of clinical pharmacology2020

First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection.

M Farouk Chughlay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.